So, You've Been Put On Clinical Hold…

As the frequency of clinical holds increases, so do the chances it’ll happen to you. What’s a biopharma leader to do if it happens? Umoja Biopharma VP of Regulatory Affairs Helen Kim and NDA Partners Regulatory Affairs Expert Consultant Daniela Drago, Ph.D. offer advice on direct engagement with the FDA to expedite the release of a clinical hold in this segment of the Bioprocess Online Live event IND Success: Navigate Through The Regulatory Gray.

View the full presentation on-demand here.